{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:14:22Z","timestamp":1782270862212,"version":"3.54.5"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"DOI":"10.1093\/infdis\/jiw544","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T07:05:57Z","timestamp":1478847957000},"page":"S130-S136","source":"Crossref","is-referenced-by-count":10,"title":["Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria"],"prefix":"10.1093","volume":"216","author":[{"given":"Soleine","family":"Scotney","sequence":"first","affiliation":[{"name":"Vaccines Delivery Team, Clinton Health Access Initiative, Nairobi, Kenya;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Snidal","sequence":"additional","affiliation":[{"name":"Vaccines Delivery Team, Clinton Health Access Initiative, Kampala, Uganda;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yauba","family":"Saidu","sequence":"additional","affiliation":[{"name":"Vaccines Delivery Team, Clinton Health Access Initiative, Yaounde, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiola","family":"Ojumu","sequence":"additional","affiliation":[{"name":"Vaccines Delivery Team, Clinton Health Access Initiative, Abuja, Nigeria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Ngatia","sequence":"additional","affiliation":[{"name":"Vaccines Delivery Team, Clinton Health Access Initiative, Nairobi, Kenya;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtala","family":"Bagana","sequence":"additional","affiliation":[{"name":"Vaccines Delivery Team, Clinton Health Access Initiative, Abuja, Nigeria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Mutuku","sequence":"additional","affiliation":[{"name":"Vaccines Delivery Team, Clinton Health Access Initiative, Nairobi, Kenya;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Sobngwi","sequence":"additional","affiliation":[{"name":"Vaccines Delivery Team, Clinton Health Access Initiative, Yaounde, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oniovo","family":"Efe-Aluta","sequence":"additional","affiliation":[{"name":"Vaccines Delivery Team, Clinton Health Access Initiative, Abuja, Nigeria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Roper","sequence":"additional","affiliation":[{"name":"Vaccines Delivery Team, Clinton Health Access Initiative, Abuja, Nigeria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"LeTallec","sequence":"additional","affiliation":[{"name":"Vaccines Delivery Team, Clinton Health Access Initiative, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Kang\u2019ethe","sequence":"additional","affiliation":[{"name":"Vaccines Delivery Team, Clinton Health Access Initiative, Nairobi, Kenya;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,30]]},"reference":[{"key":"key\n\t\t\t\t20180306121617_CIT0001","volume-title":"Poliomyelitis: Intensification of the global eradication initiative","author":"World Health Assembly"},{"key":"key\n\t\t\t\t20180306121617_CIT0002","volume-title":"Planning for IPV introduction: technical fact sheet, 2013","author":"Immunization Systems Management Group"},{"key":"key\n\t\t\t\t20180306121617_CIT0003","volume-title":"Vaccine Information Management System (VIMS) global vaccine introduction report, 2016","author":"International Vaccine Access Center"},{"key":"key\n\t\t\t\t20180306121617_CIT0004","volume-title":"Background and technical rationale for introduction of one dose of inactivated polio vaccine (IPV) in routine immunization schedule, 2014","author":"Global Polio Eradication Initiative"},{"key":"key\n\t\t\t\t20180306121617_CIT0005","volume-title":"Sage meeting of October 2015: background documents","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180306121617_CIT0006","volume-title":"Overview of the IMG structure and workstreams, 2013","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180306121617_CIT0007","volume-title":"Definition and rationale of risk tiers for IPV introduction","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180306121617_CIT0008","volume-title":"Polio eradication and endgame strategy: IPV introduction strategy and status, 2013","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180306121617_CIT0009","volume-title":"Report from Gavi: Meeting of the strategic advisory group of experts on immunization, 2015","author":"Berkley"},{"key":"key\n\t\t\t\t20180306121617_CIT0010","volume-title":"Case studies of IPV introduction: Albania, Nigeria, and Tunisia, 2015","author":"Platt"},{"key":"key\n\t\t\t\t20180306121617_CIT0011","volume-title":"CHAI lessons learned in new vaccine introduction, 2014","author":"Clinton Health Access Initiative"},{"key":"key\n\t\t\t\t20180306121617_CIT0012","volume-title":"Principles and considerations for adding a vaccine to a national immunization programme: From decision to implementation and monitoring, 2014","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180306121617_CIT0013","volume-title":"Summary of the November 2013 GAVI Alliance Board Meeting","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180306121617_CIT0014","volume-title":"Application form for country proposals: Providing support for IPV introduction, 2014","author":"Government of Kenya"},{"key":"key\n\t\t\t\t20180306121617_CIT0015","volume-title":"Application form for country proposals: Providing support for IPV introduction, 2014","author":"Government of Nigeria"},{"key":"key\n\t\t\t\t20180306121617_CIT0016","volume-title":"Application form for country proposals: Providing support for IPV introduction, 2014","author":"Government of Cameroon"},{"key":"key\n\t\t\t\t20180306121617_CIT0017","volume-title":"Polio eradication and endgame strategy: IPV introduction strategy and status, 2013","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180306121617_CIT0018","volume-title":"Multiple injections: acceptability and safety, 2014","author":"Global Polio Eradication Initiative"},{"issue":"3","key":"key\n\t\t\t\t20180306121617_CIT0019","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S2214-109X(15)00291-0","article-title":"Inactivated polio vaccine introduction in south Asia--1 year on","volume":"4","author":"Hasman","year":"2016","journal-title":"Lancet Glob Health"},{"key":"key\n\t\t\t\t20180306121617_CIT0020","volume-title":"Case studies of IPV introduction: Albania, Nigeria, and Tunisia, 2015","author":"IVAC"},{"key":"key\n\t\t\t\t20180306121617_CIT0021","volume-title":"Inactivated poliovirus vaccine supply alert","author":"UNICEF Supply Division"},{"key":"key\n\t\t\t\t20180306121617_CIT0022","volume-title":"inactivated polio virus (IPV)","author":"UNICEF. Supplies and logistics"},{"key":"key\n\t\t\t\t20180306121617_CIT0023","doi-asserted-by":"crossref","first-page":"ii62","DOI":"10.1093\/heapol\/czr049","article-title":"National decision-making on adopting new vaccines: a systematic review","volume":"27","author":"Burchett","year":"2012","journal-title":"Health Policy Plan"},{"key":"key\n\t\t\t\t20180306121617_CIT0024","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2471\/BLT.13.130146","article-title":"Health system cost of delivering routine vaccination in low- and lower-middle income countries: What is needed over the next decade?","volume":"92","author":"Lydon","year":"2014","journal-title":"Bull World Health Org"},{"issue":"5","key":"key\n\t\t\t\t20180306121617_CIT0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/heapol\/czv103","article-title":"The composition of demand for newly launched vaccines: Results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi","volume":"31","author":"Williams","year":"2016","journal-title":"Health Policy Plan"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/suppl_1\/S130\/24264795\/jiw544.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T12:16:54Z","timestamp":1520338614000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/216\/suppl_1\/S130\/3935033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,30]]},"references-count":25,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2017,6,30]]},"published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiw544","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,1]]},"published":{"date-parts":[[2017,6,30]]}}}